Sang-wahn Koo, | |
Unit 15245 Box Brian, Apo, AP 96271-5245 | |
(315) 737-5817 | |
Not Available |
Full Name | Sang-wahn Koo |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | Unit 15245 Box Brian, Apo, Armed Forces Pacific |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1083802128 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Sang-wahn Koo, Unit 15245 Box Brian, Apo, AP 96271-5245 Ph: () - | Sang-wahn Koo, Unit 15245 Box Brian, Apo, AP 96271-5245 Ph: (315) 737-5817 |
News Archive
Despite the continuing, crippling effects of a nationwide recession, a genetics research laboratory on Rutgers' Busch Campus is experiencing an economic boom.
Youngevity International, Inc., a global direct marketer of nutritional and lifestyle products and also a vertically-integrated producer of gourmet coffees for the commercial, retail and direct sales channels, announces the launch of an advanced anti-aging supplement, Imortalium into our global direct sales channel.
At the World Extreme Medicine Conference, which will take place at Dynamic Earth, Edinburgh, EH8 8AS from Saturday November 25 to Monday November 27 2017, women doctors, medics and endurance athletes will take centre stage and inspire fellow extreme medicine practitioners, clinical doctors and the next generation of the medical community.
A rigorous, long-term study of quality of life in patients who underwent one of the three most common treatments for prostate cancer found that each affected men's lives in different ways.
DARA BioSciences, Inc. announced today that on April 26, 2010, DARA Therapeutics, a subsidiary of DARA BioSciences, and the Division of Cancer Prevention, National Cancer Institute (NCI), National Institutes of Health (NIH), entered into a Clinical Trials Agreement to advance the clinical study of KRN5500 for the treatment of Chemotherapy Induced Peripheral Neuropathy (CIPN) in patients with cancer. Under the terms of the collaboration, NCI will fund the studies and DARA will supply KRN5500 and placebo.
› Verified 6 days ago
Dr. Justyna Teresa Wadolowski, D.O Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: Unit 5142, Apo, AP 96368 Phone: 315-630-4542 | |
Michael Yang, D.O Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 121 Brian Allgood Hospital, Unit 15281, Apo, AP 96205 Phone: 315-737-5668 | |
Seth Farnsworth, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 35th Medical Group, Misawa Air Base, Apo, AP 96319 Phone: 315-226-6200 | |
Dr. Susan L Hendricks, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: Unit 15244 Box 3, Usameddac-korea, Apo, AP 96205 Phone: 822-791-75508 | |
Jeff Garrett, D.O. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 35 Mdg/sgxw Unit 5024, Apo, AP 96319 Phone: 315-226-3230 | |
Monica C Scott, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: Unit 5071, Apo, AP 96328 Phone: 315-225-3566 |